Bilaketaren emaitzak - Albrecht Stenzinger

Findu emaitzak
  1. 1
    Allelic Ratio of <i>KRAS</i> Mutations in Pancreatic Cancer

    Allelic Ratio of <i>KRAS</i> Mutations in Pancreatic Cancer nork Jochen K. Lennerz, Albrecht Stenzinger

    Argitaratua 2015
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Tumor Mutational Burden as a Pan-cancer Biomarker for Immunotherapy: The Limits and Potential for Convergence

    Tumor Mutational Burden as a Pan-cancer Biomarker for Immunotherapy: The Limits and Potential for Convergence nork Antonio Passaro, Albrecht Stenzinger, Solange Peters

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    FGFR2 Inhibition in Cholangiocarcinoma

    FGFR2 Inhibition in Cholangiocarcinoma nork Arndt Vogel, Oreste Segatto, Albrecht Stenzinger, Anna Saborowski

    Argitaratua 2022
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    The combinatorial complexity of cancer precision medicine

    The combinatorial complexity of cancer precision medicine nork Frederick Klauschen, Michael Andreeff, Ulrich Keilholz, Manfred Dietel, Albrecht Stenzinger

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types

    Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types nork Jan Budczies, Carsten Denkert, Balázs Győrffy, Peter Schirmacher, Albrecht Stenzinger

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors

    Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors nork Dan Sha, Zhaohui Jin, Jan Budczies, Klaus Kluck, Albrecht Stenzinger, Frank A. Sinicrope

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination

    Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination nork Constantin Schwab, Lisa Maria Domke, Laura Hartmann, Albrecht Stenzinger, Thomas Longerich, Peter Schirmacher

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing Approach

    Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing Approach nork Volker Endris, Roland Penzel, Arne Warth, Alexander Muckenhuber, Peter Schirmacher, Albrecht Stenzinger, Wilko Weichert

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Defining molecular risk in ALK+ NSCLC

    Defining molecular risk in ALK+ NSCLC nork Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas, Albrecht Stenzinger

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Current challenges and practical aspects of molecular pathology for non-small cell lung cancers

    Current challenges and practical aspects of molecular pathology for non-small cell lung cancers nork Paul Hofman, Sabina Berezowska, Daniel Kazdal, Baharia Mograbi, Marius Ilié, Albrecht Stenzinger, Véronique Hofman

    Argitaratua 2023
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing

    Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing nork Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, Ángela Lamarca, Paul Hofman, Luigi Terracciano, Nicola Normanno

    Argitaratua 2023
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Prognostic Impact and Clinicopathological Correlations of the Cribriform Pattern in Pulmonary Adenocarcinoma

    Prognostic Impact and Clinicopathological Correlations of the Cribriform Pattern in Pulmonary Adenocarcinoma nork Arne Warth, Thomas Muley, Claudia A. Kossakowski, Albrecht Stenzinger, Peter Schirmacher, Hendrik Dienemann, Wilko Weichert

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Precision Oncology: a Clinical and Patient Perspective

    Precision Oncology: a Clinical and Patient Perspective nork Ulrik Lassen, Lydia Makaroff, Albrecht Stenzinger, Antoîne Italiano, Gilles Vassal, Jesús García‐Foncillas, Bernard Avouac

    Argitaratua 2021
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Cancer beyond organ and tissue specificity: Next‐generation‐sequencing gene mutation data reveal complex genetic similarities across major cancers

    Cancer beyond organ and tissue specificity: Next‐generation‐sequencing gene mutation data reveal complex genetic similarities across major cancers nork Daniel Heim, Jan Budczies, Albrecht Stenzinger, Denise Treue, Peter Hufnagl, Carsten Denkert, Manfred Dietel, Frederick Klauschen

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab–Docetaxel Treatment

    Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab–Docetaxel Treatment nork Ingeborg Tinhofer, Konrad Klinghammer, Wilko Weichert, Maren Knödler, Albrecht Stenzinger, Thomas Gauler, Volker Budach, Ulrich Keilholz

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

    Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic nork Timothy A. Chan, Mark Yarchoan, Elizabeth M. Jaffee, Charles Swanton, Sergio A. Quezada, Albrecht Stenzinger, Solange Peters

    Argitaratua 2018
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions

    Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decision... nork Albrecht Stenzinger, Jeffrey D. Allen, J. Maas, Mark Stewart, Diana M. Merino, Madison M. Wempe, Manfred Dietel

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  18. 18
    TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy—EGFR mutated non-small cell lung cancer IV patients treated with osimertinib

    TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy—EGFR mutated non-small cell lung cancer IV patients treated with osimertinib nork Julia Roeper, Petros Christopoulos, Markus Falk, Lukas C. Heukamp, Markus Tiemann, Albrecht Stenzinger, Michael Thomas, Frank Griesinger

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells

    Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells nork Norman Ertych, Ailine Stolz, Albrecht Stenzinger, Wilko Weichert, Silke Kaulfuß, Peter Burfeind, Achim Aigner, Linda Wordeman, Holger Bastians

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Survival of Patients with Oral Cavity Cancer in Germany

    Survival of Patients with Oral Cavity Cancer in Germany nork Stefan Listl, Lina Jansen, Albrecht Stenzinger, Kolja Freier, Katharina Emrich, Bernd Holleczek, Alexander Katalinic, Ádám Gondos, Hermann Brenner

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: